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To investigate the effects of respiration defects on the disease phenotypes, we generated trans-mito-
chondrial mice (mito-mice) by introducing a mutated G13997A mtDNA, which speciﬁcally induces
respiratory complex I defects and metastatic potentials in mouse tumor cells. First, we obtained
ES cells and chimeric mice containing the G13997A mtDNA, and then we generated mito-mice car-
rying the G13997A mtDNA via its female germ line transmission. The three-month-old mito-mice
showed complex I defects and lactate overproduction, but showed no other phenotypes related to
mitochondrial diseases or tumor formation, suggesting that aging or additional nuclear abnormal-
ities are required for expression of other phenotypes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Pathogenic mtDNA mutations that induce signiﬁcant respira-
tion defects are responsible for expression of mitochondrial dis-
eases [1–3]. Moreover, such respiration defects and the resultant
over production of reactive oxygen species (ROS) and lactate could
also be involved in aging, age-associated disorders, and tumor
development [2–5]. However, because of the control of the mito-
chondrial respiratory function by both nuclear DNA and mtDNA
[1,2], it has been difﬁcult to determine which genome, nuclear
DNA or mtDNA, is responsible for the respiration defects and the
resultant abnormalities.
Our previous study [6] resolved this issue by using complete
mtDNA exchange technology between two mouse lung carcinoma
cell lines, P29 and A11, which express different metastatic pheno-
types. The results showed that the highly metastatic A11 cells pos-
sess a somatic mtDNA mutation G13997A in the ND6 gene that
encodes NADH dehydrogenase subunit 6, one of the subunits of
respiration complex I, and that the mutation reversibly controls
development of metastases in tumor cells. Moreover, the inductionchemical Societies. Published by E
shi).of metastasis in the tumor cells was due to the complex I defects-
mediated overproduction of ROS, but not to the complex I defects-
mediated overproduction of lactate [7]. In humans, complex I de-
fects caused by pathogenic mtDNA mutations are also thought to
be responsible for expression of Leber’s hereditary optic neuropa-
thy (LHON), one of the most frequent mitochondrial diseases [1–3].
Therefore, generation of trans-mitochondrial mito-mice pos-
sessing the G13997AmtDNA introduced from highly metastatic tu-
mor cells would provide an ideal system to examine whether
somatic mtDNA mutations introduced from highly metastatic tu-
mor cells into ES cells can be transmitted to the following genera-
tions, and whether they can induce complex I defects in living
mouse tissues and induce phenotypes related to LHON, aging, and
metastasis. Here, we generated the trans-mitochondrial mito-mice
with homoplasmic G13997AmtDNA in all the tissues using mtDNA
transfer technology, and then examined the resultant phenotypes.2. Materials and methods
2.1. Cell lines and cell culture
Mouse tumor cells were grown in RPMI 1640 (Nissui Seiyaku,
Tokyo, Japan) containing 10% fetal calf serum, uridine (50 ng/ml),lsevier B.V. All rights reserved.
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established from XY TT2 cells [8]) and mtDNA-repopulated ES cells
were cultivated on mitomycin C-inactivated feeder cells derived
from fetal ﬁbroblasts, in Dulbecco’s Modiﬁed Eagle Medium
(DMEM; Invitrogen, Carlsbad, CA, USA) supplemented with 15%
KNOCKOUT™ Serum Replacement (Invitrogen), 1 non-essential
amino acids (MP Biomedicals LLC, OH, USA), leukemia inhibitory
factor (105 units/ml, Invitrogen), and 100 lM 2-mercaptoethanol
(Sigma–Aldrich, St. Louis, MO, USA).
2.2. Isolation of ESmt13997 cells carrying the imported G13997A
mtDNA
The host ES cells were pretreated with rhodamine 6G (R6G;
0.38–1.5 lg/ml in 3% ethanol) for 48 h in medium supplemented
with uridine (50 ng/ml) and pyruvate (0.1 lg/ml) to eliminate
endogenous mitochondria and mtDNA [9,10]. The ES cells were
then washed with phosphate-buffered saline (PBS) and suspended
in R6G-free medium for 2 h to allow recover. The mtDNA donor
B82mtA11 cells pretreated with cytochalasin B (10 lg/ml) for
10 min were centrifuged at 15 000g for 30 min at 37 C for enu-
cleation. The resultant cytoplasts were fused with R6G-pretreated
ES cells using polyethylene glycol, and the fusion mixture was cul-
tivated in selective medium with HAT (hypoxanthine aminopterin
thymidine). Seven days after fusion, growing colonies were picked
up for further examination.
2.3. Generation of founder chimeric mice and mito-mice13997
After frozen 8-cell-stage embryos of ICR strain mice (ARK
Resource Co., Ltd., Kumamoto, Japan) were thawed, their zona
pellucidae were removed by treatment with acidiﬁed Tyrode’s
buffer (Sigma–Aldrich). Each treated embryo was placed with 10
ESmt13997 cells in an indentation well of a 35-mm culture dish
and cultured overnight to enable aggregation. The next day, the em-
bryos were transferred into pseudopregnant ICR females (Japan
SLC). The resultant progeny were identiﬁed by their coat-color chi-
merism. Founder (F0) chimeric females were mated with C57BL/6 J
(B6; CLEA Japan) males to produce the F1 generation, and the F1
female mice were backcrossed with B6 males. The F3 generation
was used for further analyses.
2.4. Genotyping of mtDNAs
To detect the presence of the G13997A mutation, a 147-bp
fragment containing the 13997 site was ampliﬁed by PCR. The
nucleotide sequences from nucleotide position 13963 to 13996
(50-CCCACTAACAATTAAACCTAAACCTCCATActTA-30, small letters
indicate the mismatch site) and nucleotide position 14109 to
14076 (50-TTCATGTCATTGGTCGCAGTTGAATGCTGTGTAG-30) were
used as oligonucleotide primers. Combination of the PCR-gener-
ated mutation with the G13997Amutation creates a restriction site
for Aﬂ II, and generates 114-bp and 33-bp fragments on Aﬂ II diges-
tion. The restriction fragments were separated by electrophoresis
in a 3% agarose gel. For quantiﬁcation of the G13997A mtDNA,
we used the NIH IMAGE program.
2.5. Analysis of multipotency of mtDNA-repopulated ES cells
To test the multipotency of the mtDNA-repopulated ES cells, ES
cells and ESmt13997 cells, 1  106 cells of each,were inoculated sub-
cutaneously into the backs of 6-week-oldnudemice (JCL, BALB/c-nu/
nu; CLEA Japan). The resulting teratomas (tumors) were ﬁxed in 30%
neutral-buffered formalin, embedded in parafﬁn, stained with
hematoxylin and eosin (HE) and examined histologically.2.6. Biochemical measurement of respiratory enzyme activities
Mitochondrial respiratory complex I (NADH dehydrogenase),
complex II (succinate dehydrogenase), complex III (cytochrome c
reductase), and complex IV (cytochrome c oxidase) are components
of the electron-transport chain, and are located in the mitochon-
drial inner membrane. The activity of these enzymes was assayed
as described previously [11]. Brieﬂy, for the estimation of complex
I + III activity, NADH and cytochrome c (oxidized form) were used
as substrates and the reduction of cytochrome c was monitored
by measuring absorbance at 550 nm. For the estimation of com-
plexes II + III activity, sodium succinate and cytochrome c (oxidized
form) were used as substrates, and the reduction of cytochrome c
was monitored as described above. For the estimation of complex
IV activity, cytochrome c (reduced form) was used as a substrate,
and the oxidation of cytochrome c was measured at 550 nm.
2.7. Lactate measurement
To determine fasting blood lactate concentrations, blood was col-
lected from the tail veins ofmice after overnight starvation. After oral
administration of glucose (1.5 g/kg body weight), blood was again
collected, and lactate concentrations were measured using an auto-
matic blood lactate test meter (Lactate Pro, ARKRAY, Kyoto, Japan).
2.8. Measurement of ROS production
ROS generation was detected with 20,70-dichloroﬂuorescin
diacetate (DCFH-DA; Molecular Probe, Inc., Eugene, OR, USA). Cells
were incubated with DCFH-DA, washed twice, and then immedi-
ately analyzed by using a FACScan ﬂow cytometer (Becton Dickin-
son, Mountain View, CA, USA).
2.9. Western blot analysis of ROS scavenger enzymes
Tissue samples were lysed on ice in 2% SDS (Wako, Osaka,
Japan), 50 mM Tris–HCl (pH 6.8), 10% Glycerol (Wako), 5%
2-Mercaptoethanol (Wako) and 0.02% Bromophenol Blue (Wako).
After centrifugation at 45 000 rpm for 30 min at 4 C, the superna-
tant was used as a protein sample. For Western blot analysis of
manganese superoxide dismutase (MnSOD), glutathione peroxi-
dase (GPx), and catalase, the proteins were resolved by SDS–PAGE
under reducing conditions. The resolved proteins were transferred
electrophoretically to a nitrocellulose membrane (GE Healthcare
Bio-Science KK, Tokyo, Japan). The membrane was incubated with
either anti-MnSOD antibody (Upstate Biotechnology, Lake Placid,
NY, USA), anti-Glutathione Peroxidase 1 antibody (Abcam, Cam-
bridge, UK), or anti-Catalase antibody (Calbiochem, Darmstadt,
Germany) for 2 h. Proteins were detected using Immunostaining
HRP-1000 (Konica Minolta, Tokyo, Japan). An anti-b-actin antibody
(Sigma–Aldrich) was used for the loading control.
2.10. Histological analysis of eyes
Eyes with attached optic nerves were ﬁxed in 30% neutral-buf-
fered formalin and embedded in parafﬁn. Cross-sections of the op-
tic nerve and horizontal sections of the retina were stained with HE
for light microscopic examination.
3. Results
3.1. Isolation of trans-mitochondrial ES cells carrying G13997A mtDNA
To obtain trans-mitochondrial ES cells carrying the G13997A
mtDNA (ESmt13997 cells), we used mouse ES cells and mouse
Table 1
Generation of F0 chimeric mice and their F1 progeny carrying the G13997A mtDNA in
tails.
ES cells F0 mice F1 mice
ES clone % G13997A
mtDNA
% Chimerism % G13997A
mtDNA in
the tails
No. of F1 mice
with G13997A
mtDNA in the
tails/No. of F1 mice
ESmt13997-5 55 40 ($) 0 0/35
40 ($) 0 0/41
50 ($) 21 0/46
50 ($) 0 0/40
50 ($) 11 0/58
50 ($) 15 0/38
80 ($) 0 0/63
80 ($) 26 7a/23
20 (#) 0
20 (#) 0
20 (#) 0
20 (#) 0
20 (#) 0
30 (#) 0
30 (#) 19
80 (#) 23
ESmt13997-7 85 5 ($) 0 0/61
40 ($) 13 0/55
90 ($) 43 0/12
5 (#) 0
5 (#) 1
10 (#) 0
20 (#) 6
30 (#) 4
a Seven out of 23 F1 mice possessed homoplasmic G13997A mtDNA in their tails.
Two were females and ﬁve were males. We used these two F1 females for breeding,
and obtained F2 mito-mice13997. All F2 mito-mice13997 possessed homoplasmic
G13997A mtDNA in their tails. The number of F3 pups and their body weight were
comparable to those of B6 mice.
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mtDNA, respectively (Supplementary Table 1). The B82mtA11 cells
were isolated previously [6] by fusing enucleated A11 cells with
mtDNA-less B82 cells. Since the B82mtA11 cells could not survive
in the selection medium with HAT, they could be used as mtDNA
donors for mouse ES cells (Supplementary Table 1).
ES cells were pretreated with R6G to eliminate endogenous
mitochondria and mtDNA, and then fused with enucleated
B82mtA11 cells. Unfused R6G-pretreated ES cells failed to grow
due to the absence of mitochondria and mtDNA, and unenucleated
B82mtA11 cells failed to grow by the HAT selection (Supplemen-
tary Table 1).
Growing colonies in the selection medium were clonally iso-
lated, and seven clones were used for mtDNA genotyping. All seven
clones possessed various proportions of the imported G13997A
mtDNA (Fig. 1A). The mtDNA without the mutation in these clones
would be derived from feeder cells or ES cells carrying their own
mtDNA due to incomplete R6G pre-treatment. We selected two
clones, ESmt13997-5 and -7, which possessed 55% and 85%
G13997A mtDNA, respectively, as ESmt13997 cells for use in fur-
ther experiments.
3.2. Effects of the imported G13997A mtDNA on differentiation of the
ESmt13997 cells
In previous reports [12–14], chimeric mice were not obtained
from trans-mitochondrial ES cells carrying the pathogenic mtDNAs
that induce signiﬁcant respiration defects, suggesting that signiﬁ-
cant respiration defects inhibited the differentiation of multipotent
ES cells. Therefore, we tested whether the ESmt13997 cells are able
to differentiate into various tissues, by subcutaneously inoculating
ESmt13997-7 cells into the back skin of nude mice. They formed
primary tumors, which grew faster than those of the ES cells with
wild-type mtDNA (Supplementary Fig. 1A). Faster growth of the
inoculated ESmt13997 cells would be due to the induction of
hypoxia-resistant phenotypes in the cells with the G13997A
mtDNA [6].B
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plementary Fig. 1B), even though ESmt13997-7 cells showed faster
growth as primary tumors (Supplementary Fig. 1A). These observa-
tions suggested that the ESmt13997 cells could be used to obtain
F0 chimeric mice.
3.3. Generation of mito-mice13997 carrying homoplasmic G13997A
mtDNA
To generate F0 chimeric mice, ESmt13997-5 and -7 cells were
aggregated with 8-cell-stage embryos of ICR strain mice. We ob-
tained 24 F0 chimeric mice (11 females and 13 males) showing 5–
90% chimerism by coat color (Table 1). The results of mtDNA geno-
typing showed that 5 of 13 F0 males and 6 of 11 F0 females pos-
sessed 1–43% G13997A mtDNA in their tails (Table 1). Because
mouse mtDNA inherits strictly maternally [15,16], we used all 11
F0 females as founders, irrespective of whether their tails possessed
the G13997A mtDNA or not, and mated them with B6 males for
examination of its female germ line transmission to the F1 progeny.Of the 11 F0 females, only one produced F1 pups (2 females and
5 males) that possessed homoplasmic G13997A mtDNA in their
tails (Table 1). This F0 female was derived from the ES mt13997-
5 clone carrying 55% G13997A mtDNA. Probably, the ESmt13997-
5 possessed homoplasmic G13997A mtDNA, and estimation of
55% G13997A mtDNA in the clone sample (Fig. 1A) was due to
the presence of feeder cells.
Then, we examined one of the F1 males with homoplasmic
G13997A mtDNA in its tail, and showed that all tissues tested pos-
sessed homoplasmic G13997A mtDNA (Fig. 1B). This ﬁnding sug-
gests that the G13997A mtDNA transmitted maternally from an
F0 female to F1 progeny, and that the F1 mice carry the G13997A
mtDNA originally derived from highly metastatic Lewis lung carci-
noma A11 cells. Mice carrying the homoplasmic G13997A mtDNA
in all tissues were named mito-mice13997.
Our previous reports [12,17] showed that mito-mice generated
by introduction of the mtDNA with a large-scale deletion
(DmtDNA) into fertilized eggs did not possess homoplasmic
DmtDNA, because the DmtDNA induced embryonic lethality. Thus,
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(Fig. 1B) indicates that the pathogenicity of the G13997A mtDNA
was not sufﬁcient to induce embryonic lethality.
We mated two F1 female mito-mice13997 with B6 males and
obtained F2 progeny. Then, we obtained F3 progeny from seven
F2 females. Three-month-old male mito-mice13997 of the F3 gen-
eration were used for further examination of respiratory function
and disease phenotypes, while female mito-mice13997 were used
to breed and maintain the mito-mice13997 line. Genotyping of
mtDNA in one of the F3 males conﬁrmed homoplasmic G13997A
mtDNA in all the tissues tested (Fig. 1C).
3.4. Mitochondrial dysfunction and disease phenotypes in the mito-
mice13997
Using the mito-mice13997 (three-month-old F3 males), ﬁrst we
analyzed respiratory complex activities in various tissues. Tissues
from age-matched B6 mice were used as normal controls. The
activity levels of complexes II + III and complex IV in the tissues
of mito-mice13997 were not signiﬁcantly different to normal lev-
els (Fig. 2A). In contrast, all mito-mice13997 tissues tested showed
signiﬁcantly less complex I + III activity (about 70% normal level).
Since the activity of complexes II + III was normal in the mito-
mice13997 tissues, we consider that the reduced activity of com-
plexes I + III reﬂects complex I activity alone.
Our previous study [6] showed that complex I defects caused by
the G13997A mtDNA induced simultaneous overproduction of ROS
and lactate in cultivated tumor cells. So, we estimated the amounts
of ROS in the liver cells and splenocytes of the mito-mice13997 by
means of ﬂuorescence-activated cell sorting (FACS; Fig. 2B). The re-
sults showed no signiﬁcant increase in the amount of ROS in the
mito-mice13997 tissues compared to the control B6 mice. More-
over, the levels of anti-oxidant enzymes, such as MnSOD, GPx,
and catalase in the liver cells and splenocytes of the mito-
mice13997 were not signiﬁcantly different to those in the control
B6 mice (Fig. 2C). Thus, the tissues in living mice may have some
systems other than the enhanced expression of anti-oxidant en-
zymes that suppress the ROS overproduction caused by the mu-
tated mtDNA.
In contrast, after glucose loading, the lactate level in blood was
signiﬁcantly higher in mito-mice13997 than in control B6 mice
(Fig. 3A). This phenotype is also found in other mito-mice
[13,17]. Moreover, in human cases, lactic acidosis is one of the
most common phenotypes in the patients with mitochondrial dis-
eases [1–3], and our results suggest that the mito-mice13997 can
be used as models of lactic acidosis.
In humans, complex I defects caused by mtDNA mutations are
also associated with LHON [1–3]. The typical clinical features of
LHON are loss of central vision and optic nerve atrophy in young
males due to the selective loss of retinal ganglion cells, which his-
tologically correspond to the loss of the optic nerve and the loss of
both the nerve ﬁber layer and ganglion cell layer in the retina [18].
So, we histologically examined the retinal ganglion cells in three-
month-old male mito-mice13997. The results showed normal op-
tic nerve in the size and nerve ﬁber density (Fig. 3B upper panels),
and normal histology in both the nerve ﬁber layer and ganglion cell
layer in the retina (Fig. 3B lower panels). These histological obser-
vations indicated that the male mito-mice13997 did not express
the typical phenotypes of LHON [18] at least 3 months after birth.
Finally we examined the tendency to form tumors using three-
month-old mito-mice13997 of F3 generation, since their G13997A
mtDNA was derived from highly metastatic Lewis lung carcinoma
A11 cells, and they showed high lactate levels in the blood
(Fig. 3A). However, all six mito-mice13997 tested showed no bias
towards the preferential formation of tumors. These results can
be explained by the fact that the G13997A mtDNA induces metas-tasis in tumor cells, but does not induce tumor development in
normal cells [6].
4. Discussion
Because mouse G13997A mtDNA in highly metastatic tumor
cells induces respiratory complex I defects and leads to overpro-
duction of ROS and lactates [6,7], we expected that the generation
of the mito-mice13997 with homoplasmic G13997AmtDNAwould
be an effective means to examine the conventional mitochondrial
theories [2–5] proposing that ROS and lactate overproduction
caused by pathogenic mtDNA mutations is responsible for aging,
age-associated disorders, and tumor development.
As expected, the mito-mice13997 showed complex I defects
(Fig. 2A) and resultant overproduction of lactate (Fig. 3A). How-
3948 M. Yokota et al. / FEBS Letters 584 (2010) 3943–3948ever, the deﬁciency in complex I activity was less in mito-
mice13997 tissues than in the mtDNA donor B82mtA11 cells
(Fig. 2A). A similar compensatory effect was observed, when
mito-mice6589 tissues expressing complex IV defects due to
homoplasmic T6589C mtDNA mutation in the COI gene were com-
pared to their mtDNA donor cells [13]. Thus, the tissues in living
mice may have some activities that compensate for the reduced
respiration defects caused by pathogenic mtDNA mutations.
In addition, ROS overproduction, LHON phenotypes, and tumor
formation were not observed in the mito-mice13997. Probably, the
tissues in living mice are capable not only of compensating for re-
duced complex I activity, but also of suppressing ROS overproduc-
tion. In this study we used young mito-mice13997 to examine
these phenotypes. Thus, we cannot at present exclude the possibil-
ity that aging of mito-mice13997 abolishes the compensatory
function in the young tissues, resulting in expression of these phe-
notypes in aged mito-mice13997.
With respect to the LHON phenotypes, it has been proposed
that a mutation in either the ND1, ND4, or ND6 gene of mtDNA is
necessary, but not sufﬁcient to express LHON phenotypes, and that
some additional nuclear gene mutations are required [1–3]. Hence,
addition of similar nuclear gene mutations may induce the LHON
phenotypes in the mito-mice13997. The absence of tumor forma-
tion in the mito-mice13997 suggests that increased lactate levels
in the presence of oxygen, which is known as the Warburg effect
[19], were not sufﬁcient to induce tumor formation in the mito-
mice13997. Since our previous report [6] showed that the
G13997A mtDNA induces metastasis in tumor cells, but does not
induce tumor formation in normal cells, it can be expected that
the mito-mice13997 would not show tumor formation, but would
show high metastasis, only when nuclear gene mutations or a dif-
ferent nuclear background that preferentially induce tumor forma-
tion were introduced.
Therefore, aging of the mito-mice13997 and/or the introduction
of different nuclear backgrounds or nuclear gene abnormalities
into the mito-mice13997 would be important for further investiga-
tion of the capability of the mito-mice13997 to express signiﬁcant
complex I defects, ROS overproduction, tumor formation, metasta-
sis, and the phenotypes related to LHON and aging.Acknowledgements
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